The latest research suggests that a relatively new turmeric-based supplement—tetrahydrocurcumin—may be more effective for addressing gastrointestinal symptoms, particularly when delivered in highly bioavailable forms.
Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) which causes patients to experience a higher than normal number of daily stools, bloody or disrupted stools, diarrhea, pain, weight loss, inflammation, and bloating.
For patients with ulcerative colitis, developing an effective management strategy can be a major challenge. Symptoms vary widely between patients, and many of the most common therapeutics—including aminosalicylates.
Conventional treatments for ulcerative colitis suffer from both tolerability and efficacy issues, spurring clinicians and patients to increasingly seek out natural ulcerative colitis therapy options.
Compelling evidence has begun to emerge in support of modern dietary interventions for those who seek to alleviate IBD symptoms noninvasively, including the FODMAP diet and targeted nutraceutical interventions.
The use of antibiotics is all too common in modern medicine, with risks that are becoming increasingly evident. While they are literally life-saving in many instances, they may also lead to antibiotic-induced colitis in some patients.